Mixing and Matching: Layering Medications as Family Physicians OCFP Annual Scientific Assembly Toronto, Ontario November 30, 2013 Jon Davine, CCFP, FRCP©

Slides:



Advertisements
Similar presentations
Approach to Depression in primary care
Advertisements

Pharmacologic Treatments. 2 Cognitive Behavioural Therapy (CBT) Psychosocial Interventions.
Guy Brookes Leeds PFT.  Antipsychotic Medication  Antidepressant Medication  Mood Stabilisers  What does the Evidence mean?
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Treating Depression in the Primary Care Setting Pharmacologic Interventions Presented by: Jonathan Betlinski, MD Date: 09/25/2014.
Intro to Psychopharmacology Caitlin Stork, MD. Besides dopamine blockade... ReceptorEffect of Blockade Acetylcholine (muscarinic; M1) Anticholinergic.
University Hospital “Sisters of Charity” Psychiatric Clinic Vinogradska c. 29, 1000 Zagreb, Croatia Davor Moravek Addiction and psychotic.
Module 4: Interaction of. Objectives To be aware of the possible reasons why dual diagnosis occurs To be aware of the specific effects of substances on.
Treating Bipolar Disorder in the Primary Care Setting
2007. Statistics  2-4 new cases per 100,000/year  1 in 200 people will have an episode of hypomania  Peak age of onset yrs  May have had a previous.
Depression Ibrahim Sales, Pharm.D. Associate Professor of Clinical Pharmacy King Saud University
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Adjuvancy strategies of medicines are commonly classified into ‘‘augmentation” and ‘‘combination” approaches introduction :
Bipolar Disorders.
OCFP Annual Scientific Assembly Toronto, Ontario November 30, 2013
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Bipolar disorder (BD) is a psychological disorder that is characterized by episodes if depression alternating with episodes of mania. During a depressive.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 33 Drugs for Bipolar Disorder.
Major Depressive Disorder Presenting Complaints
New treatment options for use in bipolar mania Dr C Verster Dept Psychiatry Uuniversity of Stellenbosch.
Mood Disorders and Suicide
Pharmacotherapy of Functional Mental Illness in the Elderly. Virupakshi Jalihal Locum Consultant Psychiatrist Cornwall Partnership NHS Foundation Trust.
Mood Disorders. Major Depressive Disorder  Five or more symptoms present for two weeks or more:  Disturbed Mood  depressed mood  anhedonia (reduced.
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Chapter 7 Mood Disorders and Suicide
Bipolar I Disorder Treatment. Therapeutic Goals Relief of immediate symptoms Improvement of patient’s well-being Elimination of stressors Combined pharmacotherapy.
Basics of outpatient depression management Chris Zamani MD.
Strategies to Switch Antidepressants Brittany Parmentier, PharmD PGY2 Behavioral Care Resident Butler University/Community Health Network This speaker.
Treatment Strategy Hierarchy Safety: stabilize suicidality, homocidality, self harm, acting out Psychosis: treat aggressively, rule out delirium,
for the Psychiatry Clerkship is proud to present And Now Here Is The Host... Insert Name Here.
 characterized by positive and negative symptoms ◦ positive symptoms – those that can be observed; ex. hallucinations ◦ negative symptoms – absence of.
OCD, PTSD, and Panic Disorders. OCD Biological basis remains unknown But there seems to be some genetic component related to OCD and other anxiety disorders.
PSYCHIATRIC DRUGS Chapter 13. Psychiatric Drugs  Treat mood, cognition, and behavioral disturbances associated with psychological disorders  Psychotropic.
Maryam Tabatabaee M.D Assistant professor of psychiatry.
BIPOLAR DISORDER DR GIAN LIPPI CONSULTANT PSYCHIATRIST
Pharmacotherapy in Psychotic Disorders. Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: –
Bipolar Disorder Dakota Miller Micah Moyer. What is it? Bipolar disorder is a mental illness. It is also classified as a mood disorder. Causes unusual.
Treatment Resistant Pediatric BD Elham Shirazi M.D. Board of General Psychiatry Board of Child & Adolescent Psychiatry.
Depression Dr. Alan Ng Behavioural Medicine. Reference Psychiatry in Primary Care Editors: Goldbloom, Davine CAMH, Toronto 2011.
Psychotropic Medication Management on Center David P. Kraft, MD, MPH Region I Mental Health Consultant National Health and Wellness Conference Orlando,
Mood Disorders By: Angela Pabon.
BIPOLAR DISORDER, DR GIAN LIPPI CONSULTANT PSYCHIATRIST UNIVERSITY OF PRETORIA & WESKOPPIES HOSPITAL FORENSIC UNIT MANAGEMENT GUIDELINES.
Drugs for Bipolar Disorder. Bipolar Disorder  Formerly known as manic-depressive illness  Afflicts an estimated 3.7% of the adult population  Mainstays.
Citalopram 20 Mg Cheap Citalopram Hydrobromide No Prescription nucynta and celexa pseudoephedrine celexa celexa sleep too much how much seroquel for depression.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparative Mortality Risk in Adult Patients With.
PSY 6670 Diagnosis & Treatment Planning Lecture 5 : Mood & Anxiety Related Disorders & Treatment Planning Joel Fairbanks, Ph.D.
By dr.safeyya alchalabi
Module 3 Use of antipsychotics for unipolar depression
Ch. 13: Biomedical Therapy: Biological Approaches to Treatment
Bipolar Disorder MED 2017.
Module 3 Indications for Antipsychotics Bipolar Disorder
One-Year Weight Gain While on Treatment with an Antipsychotic
for the Psychiatry Clerkship
Psychiatric Drugs Chapter 13.
Drugs for Bipolar Disorder
Michael Panzer, MD ThedaCare Behavioral Health
Introduction to bipolar disorder
Other drugs used in the treatment of bipolar disorder
Clinical pharmacology of antipsychotic agents
BIPOLAR DISORDER Insert name of instructor, title, and contact information.
Chapter 7 The Science of Psychopharmacology
PHARMACOTHERAPY - I PHCY 310
Chapter 9: Community Pharmacy
University of Nizwa College of Pharmacy and Nursing School of Pharmacy
CHAPTER 21 Drugs and other physical treatments
Obsessive-Compulsive Disorder: Pharmacotherapy
PHARMACOTHERAPY - I PHCY 310
Module 3 Indications for Antipsychotics Bipolar Disorder
Dr James Ovens Consultant Psychiatrist Tandridge CMHRS
Presentation transcript:

Mixing and Matching: Layering Medications as Family Physicians OCFP Annual Scientific Assembly Toronto, Ontario November 30, 2013 Jon Davine, CCFP, FRCP© McMaster University

Faculty/Presenter Disclosure Faculty: Jon Davine Faculty: Jon Davine Program: 51 st Annual Scientific Assembly Program: 51 st Annual Scientific Assembly Relationships with commercial interests: Relationships with commercial interests: Lundbeck, Canada: Educational presentations Advisory Board member

Disclosure of Commercial Support This program has received NO financial support This program has received NO financial support This program has received NO in-kind support This program has received NO in-kind support Potential for conflict(s) of interest: Potential for conflict(s) of interest: – NONE

Mitigating Potential Bias I am not discussing any of Lundbeck Canada’s drugs in this presentation I am not discussing any of Lundbeck Canada’s drugs in this presentation When discussing pharmacotherapy, I will be using CANMAT guidelines When discussing pharmacotherapy, I will be using CANMAT guidelines

Depression Augmentation Partial Response of Depression, ONLY. Augment after maximizing original antidepressant This may involve going over the usual maximum Involves the highest dose without side effects

Depression Augmentation Wellbutrin XL 150 mg. po qam x 2-3 weeks, then 300 mg. po qam (Range mg./day)’ I use when more of a psychomotor retarded state, increased sleep, etc. Remeron 15 mg. po qhs x 2-3 weeks, increase by 15 mg. increments (Range mg./day) I use when more of an agitated state (decreased sleep, anxious, etc.) This are referred to as combination/augmentation

Depression Augmentation-CANMAT First Line Options: Lithium Aripiprazole Risperidone Olanzapine (with Fluoxetine)

Lithium mg./day Continue for duration of treatment

Depression Augmentation--Atypicals Risperidone 0.5—1.0—1.5—2.0 mg./day Aripiprazole 2.5—5.0—7.5 mg./day Olanzapine 2.5—5.0—7.5 mg./day

Augmentation--Cytomel Considered second line according to CANMAT guidelines Start Cytomel(T3), 25 micrograms po once daily x 2-3 weeks Depending on response, can increase to 50 micrograms po once daily Literature reports 50% efficacy

Augmentation--Quetiapine This only has second line approval according to CANMAT I still use it because it has approval for bipolar depression, and monotherapy in unipolar depression when no other antidepressants have worked Dose is 50—100—150mg./day Have to do fasting metabolic q4monthly while on this

Sleep meds Can be used in addition to antidepressants or antipsychotics I prefer Trazodone mg. po hs. Can increase by 25 mg. increments as necessary Can go up to 75, 100, or 150 mg./day

Sleep Meds I would then use Zopiclone mg. po hs Can increase by 3.75 mg. increments. Range is up to 15 or even 22.5 mg. hs This pill is addictive, though apparently not as much as the benzodiazepines

Sleep Meds Benzos Use mid half life (8-14 hours). Not short, not long I prefer: Lorazepam 1-2 mg. po hs Oxazepam mg. po hs Clonazepam, Diazepam-- long half life Triazolam is short half life These are addictive

Lamotrigine in Bipolar Depression Lamotrigine Sometimes added to lithium as mood stabilizer It works better from the “bottom up” Lithium and Epival work better from the “top down” Lamictal Level 1 (A) for bipolar depression

Bipolar Depression 20% of Bipolar Depressive Episodes run a chronic course Mild depressive symptomatology may be successfully treated with CBT or IPT Lithium Response rates from 64% to 100%. Level I (A) evidence Antidepressants Level I (B) evidence. Watch for flips (more common with tricyclics) Use with concomitant mood stabilizer to avoid flips

CANMMAT (09):1 st Line Treatments for Bipolar Depression Monotherapy: Lithium, lamotrigine, quetiapine Combination Therapy: Lithium and divalproate Lithium or divalproate plus SSRI or buproprion Olanzapine and SSRI

Tricyclics Sometimes tricyclics are used for sleeping. Typically Amitryptyline or Nortriptyline. I would always use Nortriptyline due to more favourable side effect profile. Start at 10 mg. po hs and increase by 10 mg. increments qweekly. Usual range is mg. hs

Tricyclics Also useful for pain management, both organically based and psychologically amplified I would also do an EKG as dosing rises as they are type 1 antiarrhythmics (quinidine effect)

When NOT to Mix Be aware of certain P450 Cytochrome problems: P450 2D6 If using Codeine for pain relief. This goes to desmethylcodeine, the active ingredient, through 2D6 Fluoxetine and Paroxitene block 2D6. Don’t use with codeine

Risperidone, Olanzapine, Quetiapine, Ziprasidone and Aripiprazole are all approved for use as anti manic agents Risperidone--1-4 mg/day Olanzapine 5-20 mg/day Quetiapine mg/day Aripiprazole mg/day Ziprasidone mg BID Atypical Neuroleptics

CANMMAT (09):1 st Line Treatments for Mania Monotherapy: Lithium, divalproex, Risperidone, Olanzapine, Quetiapine, Ziprasidone, Aripiprazole Combination: Lithium or divalproex plus Atypicals, except Ziprasidone (increases response by 20%) Rapid Cycling/Mixed: Divalproex **Discontinue antidepressant, stimulant meds

When NOT to Mix Coumadin is metabolized through P450 1A4 Fluvoxamine blocks 1A4 This don’t use with Coumadin

When NOT to Mix Amitriptyline and Nortriptyline are metabolized through P450 2D6. These can be used for sleep or pain control Thus do not use with Fluoxetine or Paroxitene Level may rise up to 2-3 times

When NOT to Mix Never use a reuptake inhibitor (SSRI, SNRI, DNRI, NaSSA) along with a degradation blocker (MAOI, RIMA) Need 2 weks washout Hypertensive Crisis, Serotonergic Syndrome

Bipolar- Mania If someone is manic, there are two or three drugs we would use together First, start with a mood stabilizer Lithium and Epival both have anti manic effects. Lamictal does not Usual starting dose is Lithium 300 mg. po bid. For Epival, it is 250 mg. po bid

Bipolar--Mania Can increase Lithium by 300 mg. increments qweekly until in range Do 12 hour trough levels qweekly to see if adjustment needed Can do the same for Epival, except start at 250 mg.pobid, and increase by 250 mg. increments

Atypical Neuroleptics in Bipolar Depression Atypical Neuroleptics can be used as acute antidepressants Quetiapine now approved for bipolar depression (CANMMAT) I use less because of metabolic issues.

Anti Psychotics In Bipolar Mania These are used along with mood stabilizer as both anti- manic and anti-psychotics CANMAT recommends: Risperodone, Quetiapine, Olanzapine, Ziprasidone, Aripiprazole

Anti-Psychotics We keep using the antipsychotics until approximately two months of stabillity—psychosis free and mania free Then we would wean off the neuroleptics over the next month. The goal is just to be on a mood stabilizer once the acute episodde has pased

Mania—Benzodiazepines Benzos are often used in acute manic episodes I would recommend clonazepam as it has a long half life Usual dose is mg. po bid to tid We wean people off this fairly quickly, usually days to weks

Bipolar Depression If on Lithium, can first increase lithium to a somewhat higher level Lithium has Level 1A evidence as an acute anti depressant for bipolar depression Can add Lamotrigine to the mood stabilizer. This also has Level 1A evidence as an acute antidepressant for bipolar depression.

Bipolar Depression--Antidepressants Interestingly, antidepresants only have Level 1B evidence for bipolar depression Important never to use a “naked” antidepressant if someone is bipolar NB: In primary care, if someone presents with a unipolar depression, ALWAYS screen for past hypomanic episodes